Figure INF-4:  Trends in HIV prevalence among injecting drug users estimated from national and sub-national samples, 1995 to 2004 – Part (iii) New injecting drug users (injecting less than 2 years)

Notes:

UK data are for IDUs injecting less than 3 years. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Data for Portugal and Italy and part of the data for Czech Republic and France include non-IDUs and therefore may underestimate prevalence among IDUs (estimated proportion of non-IDUs in the samples: Italy 5-10 %, Czech Republic, France and Portugal not known).

Data for Belgium, Italy, Portugal and Slovakia are limited to prevalence among IDUs in treatment and may not be representative of prevalence among IDUs who are not in treatment. In addition, data may not be representative for people who are in treatment - this is known to be the case for Belgium.

Data for Luxembourg and France, and part of the data for Czech Republic, are based on self-reported test results, which are less reliable than clinically documented tests.

* Spain: Excluding communities of Madrid and La Rioja

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national focal points.